why choose us

First received: October 30, 2024

Clinical Trial: Role of BARriers in IgG-Pathogen Interactions at the Mucosal Surface in Human Airways

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Bronchiectasis Adult

Study Type: INTERVENTIONAL


Official Title: Role of BARriers in IgG-Pathogen Interactions at the Mucosal Surface in Human Airways

Brief Summary: Context. Non cystic fibrosis bronchiectasis (NCFB) is a group of suppurative chronic airway diseases of multiple causes. Bronchiectasis is characterized by an abnormal, irreversible dilatation of the bronchi, airway obstruction, chronic cough, and sputum production. Inhaled polyclonal immunoglobulin G (IgG) is a new therapeutic approach for NCFB. Inhaled IgG is expected to have beneficial effects due to its ability to reduce the range of respiratory pathogens capable of infecting the respiratory tract, decrease…

Read more